Upgrade to SI Premium - Free Trial

BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $90; Piper Sandler: 'Remain Buyers'

September 1, 2026 7:30 AM
(Updated - September 1, 2026 9:00 AM EDT)

Piper Sandler analyst Allison M. Bratzel raised the price target on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change